NIH-funded research R01 grant

Exploring how environmental factors cause mutations in cancer

Official title: Understanding the origins of the mutational landscape in cancer

Funded at Univ of Arkansas for Med Scis · NIH-11022399 · Data updated 2026-11-12

This study is looking at how harmful substances in our environment can damage our DNA and possibly lead to cancer, with the goal of finding ways to improve prevention and treatment for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Arkansas for Med Scis
NIH-funded
Lab location1 site (Little Rock, United States)
Project startFebruary 24, 2025
Project endJanuary 31, 2028
Funding year2025
Award (this year)$749,901
NIH project number1R01ES036931-01
Project IDNIH-11022399 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of exposure to environmental toxins or those diagnosed with cancer.

Less likely to help

Patients who have no history of environmental toxin exposure or who do not have cancer may not receive direct benefits from this research.

What this research studies

This research investigates how exposure to environmental toxins leads to DNA damage, which can result in mutations that contribute to cancer development. By analyzing the types of DNA lesions and their locations within the genome, the study aims to clarify the connection between these lesions and the mutations observed in various cancers. The approach combines advanced techniques such as DNA adductomics and long-read sequencing to provide a comprehensive understanding of the mutational landscape. Patients may benefit from insights that could lead to better prevention and treatment strategies for cancer.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding of cancer mutations, potentially guiding more effective prevention and treatment strategies.

How similar studies have gone: Previous research has shown promising results in understanding the relationship between DNA damage and cancer mutations, indicating that this approach could yield valuable insights.

Where this research is happening

  • Univ of Arkansas for Med Scis
    Little Rock, United States
    Active

Researchers

  • Principal investigator: Boysen, Gunnar — Univ of Arkansas for Med Scis
  • Study coordinator: Boysen, Gunnar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.